Genmab — December 2015
-
Jeps. Eksklusiv adgang til deres SC teknologi
-
det er et valg man tager
-
Meget få bivirkninger.
-
Det er jo ofte nemmere at finde egnede patienter så. især fordi de rekrutterer mindre syge til de store phase III forsøg
-
igen - Helge må kunne lide vandfaldet
-
ja noget med at Keytruda gav lungesygdom !
-
Det hører vi mange gange i aften.
-
imponerende at alle dara data viser det samme - "i er jo tossede, at det her ikke er 1st line endnu!"
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind